David H Mulama

Title: David H Mulama: Innovator in Vaccine Development

Introduction

David H Mulama is a notable inventor based in Duarte, California. He has made significant contributions to the field of vaccine development, particularly in relation to Kaposi sarcoma-associated herpesvirus (KSHV). His innovative work focuses on creating effective vaccine compositions to prevent and treat KSHV infections.

Latest Patents

David H Mulama holds a patent for "Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof." This patent describes vaccine compositions that comprise a single KSHV-like particle containing two or more KSHV glycoproteins and/or one or more T cell antigens. The patent also outlines methods for preventing or treating KSHV infections using these vaccine compositions. Additionally, it details an expression system or a single expression vector designed for the co-expression of multiple KSHV glycoproteins simultaneously, which is essential for generating a vaccine comprising a single virus-like particle.

Career Highlights

David is currently associated with City of Hope, a prominent research and treatment center. His work at City of Hope emphasizes the importance of innovative approaches in combating viral infections through vaccine development. His dedication to research and innovation has positioned him as a key figure in the field.

Collaborations

David has collaborated with several talented individuals, including Javier Gordon Ogembo and Lorraine Zvichapera Mutsvunguma. These collaborations have further enhanced the research efforts in developing effective vaccine solutions.

Conclusion

David H Mulama's contributions to vaccine development, particularly in relation to KSHV, highlight his innovative spirit and commitment to advancing medical science. His work continues to inspire future research in the field of infectious diseases.